全文获取类型
收费全文 | 2754884篇 |
免费 | 248103篇 |
国内免费 | 15013篇 |
专业分类
耳鼻咽喉 | 38511篇 |
儿科学 | 83863篇 |
妇产科学 | 70669篇 |
基础医学 | 454338篇 |
口腔科学 | 75504篇 |
临床医学 | 243220篇 |
内科学 | 469920篇 |
皮肤病学 | 80049篇 |
神经病学 | 238567篇 |
特种医学 | 109612篇 |
外国民族医学 | 108篇 |
外科学 | 442177篇 |
综合类 | 90746篇 |
现状与发展 | 24篇 |
一般理论 | 2050篇 |
预防医学 | 222307篇 |
眼科学 | 63727篇 |
药学 | 192157篇 |
18篇 | |
中国医学 | 9436篇 |
肿瘤学 | 130997篇 |
出版年
2021年 | 49140篇 |
2020年 | 34870篇 |
2019年 | 57736篇 |
2018年 | 69532篇 |
2017年 | 52535篇 |
2016年 | 57984篇 |
2015年 | 72853篇 |
2014年 | 106975篇 |
2013年 | 171882篇 |
2012年 | 73530篇 |
2011年 | 70013篇 |
2010年 | 111126篇 |
2009年 | 117287篇 |
2008年 | 57503篇 |
2007年 | 58015篇 |
2006年 | 69775篇 |
2005年 | 64930篇 |
2004年 | 67139篇 |
2003年 | 58506篇 |
2002年 | 48161篇 |
2001年 | 78343篇 |
2000年 | 69539篇 |
1999年 | 73385篇 |
1998年 | 56901篇 |
1997年 | 55257篇 |
1996年 | 52287篇 |
1995年 | 53091篇 |
1994年 | 47297篇 |
1993年 | 44311篇 |
1992年 | 49010篇 |
1991年 | 45859篇 |
1990年 | 42608篇 |
1989年 | 43021篇 |
1988年 | 39702篇 |
1987年 | 38631篇 |
1986年 | 36428篇 |
1985年 | 37174篇 |
1984年 | 36688篇 |
1983年 | 34314篇 |
1982年 | 37125篇 |
1981年 | 35249篇 |
1980年 | 33222篇 |
1979年 | 27725篇 |
1978年 | 27083篇 |
1977年 | 25746篇 |
1976年 | 22879篇 |
1975年 | 20941篇 |
1974年 | 19970篇 |
1973年 | 19051篇 |
1972年 | 17993篇 |
排序方式: 共有10000条查询结果,搜索用时 290 毫秒
61.
Timothy J. Cordingley Mark A.G. Wilson Kathryn M. Weston 《Health & social care in the community》2022,30(1):353-359
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children. 相似文献
62.
Medicine, Health Care and Philosophy - In this paper, I will provide a phenomenological analysis of somatic obsessions at times present in obsessive–compulsive disorder. I will compare two... 相似文献
63.
Münch F. Purbojo A. Wenzel F. Kohl M. Dittrich S. Rauh M. Zimmermann R. Kwapil N. 《Der Anaesthesist》2022,71(11):882-892
Die Anaesthesiologie - Die Transfusion von Erythrozytenkonzentraten (EK) ist mit verschiedenen Nebenwirkungen assoziiert, die u. a. durch Lagerungsschäden an Erythrozyten hervorgerufen... 相似文献
64.
Alicia C. McDonald PhD MPH Jeremy Gernand PhD Nathaniel R. Geyer DrPH Hongke Wu MD MPH Yanxu Yang MPH Ming Wang PhD 《Cancer》2022,128(9):1832-1839
65.
Robert J. Motzer MD David F. McDermott MD Bernard Escudier MD Mauricio Burotto MD Toni K. Choueiri MD Hans J. Hammers MD PhD Philippe Barthélémy MD PhD Elizabeth R. Plimack MD Camillo Porta MD Saby George MD Thomas Powles MD Frede Donskov MD PhD Howard Gurney MD Christian K. Kollmannsberger MD Marc-Oliver Grimm MD Carlos Barrios MD Yoshihiko Tomita MD PhD Daniel Castellano MD Viktor Grünwald MD PhD Brian I. Rini MD M. Brent McHenry PhD Chung-Wei Lee MD PhD Jennifer McCarthy MA Flavia Ejzykowicz PhD Nizar M. Tannir MD 《Cancer》2022,128(11):2085-2097
66.
67.
68.
Li Dong Mari Nygård Nathalie C. Støer Ole Klungsøyr Bo T. Hansen 《International journal of cancer. Journal international du cancer》2023,153(2):399-406
Human papillomavirus (HPV) vaccine effectiveness may differ between settings. Here we present the first real-world effectiveness study of HPV vaccination on high-grade cervical lesions from Norway, among women who received HPV vaccine outside the routine program. We performed an observational study of all Norwegian women born 1975 to 1996 and retrieved individual data from nationwide registries on HPV vaccination status and incidence of histologically verified high-grade cervical neoplasia during 2006 to 2016. We estimated the incidence rate ratio (IRR) and 95% confidence intervals (CI) for vaccination vs no vaccination by Poisson regression stratified by age at vaccination <20 years and ≥20 years. The cohort consisted of 832 732 women, of which 46 381 (5.6%) received at least one dose of HPV vaccine by the end of 2016. The incidence rate of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) increased with age regardless of vaccination status and was highest at age 25 to 29, at 637/100 000 among unvaccinated women, 487/100 000 among women vaccinated before age 20 and 831/100 000 among women vaccinated at age 20 or older. The adjusted IRR of CIN2+ between vaccinated and unvaccinated women was 0.62 (95% CI: 0.46-0.84) for women vaccinated below age 20, and 1.22 (95% CI: 1.03-1.43) for women vaccinated at age 20 or older. These findings indicate that HPV vaccination among women too old to be eligible for routine HPV vaccination is effective among women who are vaccinated below age 20 but may not have the desired impact among women who are vaccinated at age 20 or older. 相似文献
69.
Georgios D. Lianos MD PhD Maximos Frountzas MD MPA PhD Dimitrios Schizas MD PhD Evangelos G. Baltagiannis MD George A. Alexiou MD PhD Christina Bali MD PhD Georgios K. Glantzounis MD PhD Michail Mitsis MD PhD Konstantinos Vlachos MD PhD 《Journal of surgical oncology》2023,127(1):7-10
During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered. 相似文献
70.